This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Sirnaomics, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations of Xiaoyong Lu in Targeted Nucleic Acid Delivery
Introduction
Xiaoyong Lu is an accomplished inventor based in Gaithersburg, MD, known for his significant contributions to the field of targeted nucleic acid delivery. His innovative work focuses on enhancing therapeutic benefits through advanced peptide docking vehicles.
Latest Patents
Xiaoyong Lu holds a patent for a "Peptide docking vehicle for targeted nucleic acid delivery." This patent describes peptide docking vehicle compositions that contain therapeutic compounds, such as siRNA molecules, linked to targeting ligands. These compositions and methods facilitate targeted delivery of therapeutic compounds to specific cells or tissues, providing enhanced therapeutic benefits for both animals and humans.
Career Highlights
Lu is associated with Sirnaomics, Inc., where he applies his expertise in developing innovative solutions for nucleic acid delivery. His work has been instrumental in advancing the field and improving treatment options for various medical conditions.
Collaborations
Some of his notable coworkers include Patrick Y Lu and David M Evans, who contribute to the collaborative efforts at Sirnaomics, Inc. Their combined expertise fosters an environment of innovation and progress in the field of targeted therapies.
Conclusion
Xiaoyong Lu's contributions to the field of targeted nucleic acid delivery exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in therapeutic delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile